These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7434268)

  • 1. Clinical and haemodynamic effects of diazoxide in primary pulmonary hypertension.
    Honey M; Cotter L; Davies N; Denison D
    Thorax; 1980 Apr; 35(4):269-76. PubMed ID: 7434268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diazoxide in treatment of primary pulmonary hypertension.
    Wang SW; Pohl JE; Rowlands DJ; Wade EG
    Br Heart J; 1978 May; 40(5):572-4. PubMed ID: 656227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reassessment of the effects of vasodilator drugs in primary pulmonary hypertension: guidelines for determining a pulmonary vasodilator response.
    Rich S; Martinez J; Lam W; Levy PS; Rosen KM
    Am Heart J; 1983 Jan; 105(1):119-27. PubMed ID: 6849224
    [No Abstract]   [Full Text] [Related]  

  • 4. Reversibility of primary pulmonary hypertension during six years of treatment with oral diazoxide.
    Chan NS; McLay J; Kenmure AC
    Br Heart J; 1987 Feb; 57(2):207-9. PubMed ID: 3814459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diazoxide in primary pulmonary hypertension.
    Klinke WP; Gilbert JA
    N Engl J Med; 1980 Jan; 302(2):91-2. PubMed ID: 7350437
    [No Abstract]   [Full Text] [Related]  

  • 6. Diazoxide for hypertensive crisis.
    Vidt DG
    Am Fam Physician; 1975 May; 11(5):128-30. PubMed ID: 1130248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasodilators and prostaglandin inhibitors in primary pulmonary hypertension.
    Hermiller JB; Bambach D; Thompson MJ; Huss P; Fontana ME; Magorien RD; Unverferth DV; Leier CV
    Ann Intern Med; 1982 Oct; 97(4):480-9. PubMed ID: 7125407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of diazoxide on severe pulmonary hypertension].
    Raimondi GA
    Medicina (B Aires); 1990; 50(3):198-204. PubMed ID: 2130205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous diazoxide in treatment of hypertension associated with recent myocardial infarction.
    O'Brien KP; Grigor RR; Taylor PM
    Br Med J; 1975 Oct; 4(5988):74-7. PubMed ID: 1182475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute pulmonary vasodilatory properties of amlodipine in humans with pulmonary hypertension.
    Woodmansey PA; O'Toole L; Channer KS; Morice AH
    Heart; 1996 Feb; 75(2):171-3. PubMed ID: 8673756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonemergency use of slow infusions of diazoxide.
    Lee WR; Mroczek WJ; Davidov ME; Finnerty FS
    Clin Pharmacol Ther; 1975 Aug; 18(2):154-7. PubMed ID: 1097151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Profile of paediatric patients with pulmonary hypertension judged by responsiveness to vasodilators.
    Houde C; Bohn DJ; Freedom RM; Rabinovitch M
    Br Heart J; 1993 Nov; 70(5):461-8. PubMed ID: 8260279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diazoxide in treatment of primary pulmonary hypertension.
    Rubino JM; Schroeder JS
    Br Heart J; 1979 Sep; 42(3):362-3. PubMed ID: 508461
    [No Abstract]   [Full Text] [Related]  

  • 14. Primary pulmonary hypertension: effects of nifedipine.
    Camerini F; Alberti E; Klugmann S; Salvi A
    Br Heart J; 1980 Sep; 44(3):352-6. PubMed ID: 7426194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The importance of the rapid administration of diazoxide in accelerated hypertension.
    Mroczek WJ; Leibel BA; Davidov M; Finnerty FA
    N Engl J Med; 1971 Sep; 285(11):603-6. PubMed ID: 5563961
    [No Abstract]   [Full Text] [Related]  

  • 16. [Short- and long-term effects of the new oral prostacyclin analogue, beraprost sodium, in patients with severe pulmonary hypertension].
    Saji T; Ozawa Y; Nakayama T; Matsuura H; Hashiguchi R; Matsuo N; Muto H; Yamazaki J; Morishita T; Saito T
    J Cardiol; 1996 Apr; 27(4):197-205. PubMed ID: 8642506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasodilator therapy for pulmonary hypertension.
    Cotter L; Honey M
    N Engl J Med; 1980 May; 302(22):1260. PubMed ID: 7366683
    [No Abstract]   [Full Text] [Related]  

  • 18. Hazards of diazoxide in pulmonary hypertension.
    Buch J; Wennevold A
    Br Heart J; 1981 Oct; 46(4):401-3. PubMed ID: 7295436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse effect of hydralazine in patients with primary pulmonary hypertension.
    Kronzon I; Cohen M; Winer HE
    JAMA; 1982 Jun; 247(22):3112-4. PubMed ID: 7077805
    [No Abstract]   [Full Text] [Related]  

  • 20. Diazoxide in the management of severe hypertension.
    Moller BB; Kolendorf K
    Acta Med Scand; 1975 Nov; 198(5):358-8. PubMed ID: 1199811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.